
usd feb pm et
summari compani provid broad rang manag health care plan servic
individu well group militari
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
pm stock trade
target price recent
chang highlight
section stock report updat
invest rationale/risk section
stock report updat shortli
latest news stori marketscop
drop target
ep estim
histor forward price-to-earnings averag due
worse-than-expect margin ep
vs consensu
rais ep estim
start
primarili higher price medicar plan
membership medicare-focus retail
segment gener approxim
oper revenu slightli vs
prior-year period howev think
due intens competit among insur
still
manag grow medicar membership
substanti medic cost
oper expens also grew faster
revenu lead yoy declin
adjust pre-tax incom sg expens
ratio bp yoy remain
neutral would like see better execut
cost contain /colin scarola
risk assess reflect heavi relianc
manag medicar plan growth competit
new member space intens insur
compet member often lower requir
premium plan bring new revenu
also lower profit margin see manag
risk well demonstr strong price
disciplin plan maintain margin also
face risk higher-than-expect health care util
rate increas benefit cost recent
acquisit health care provid help mitig
risk view
may ep estim base cfra oper earn
histor earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
chairman board
corpor overview one largest manag care organ
million member medic benefit plan million member specialti product june
compani oper three segment retail employ group
retail segment includ product sold retail basi individu includ medic supplement
benefit plan compani particip medicar program privat health plan
membership base provid compani abil expand network ppo hmo provid
compani employ strategi includ health assess clinic guidanc program
lifestyl fit program senior guid medicar beneficiari make decis respect
health care
individu medicar advantag product compani contract medicar advantag
program provid rang health insur benefit includ well program chronic care
manag care coordin medicar elig person hmo ppo privat
fee-for-servic pff plan exchang contractu payment receiv usual fix
payment per member per month product beneficiari receiv benefit excess
medicar ff includ reduc cost share improv prescript drug benefit care coordin
data analysi techniqu help identifi member need complex case manag tool guid
member health care decis care manag program well prevent program
instanc reduc monthli part premium major medicar advantag plan offer
prescript drug benefit part part basic plan subject cost share
limit medicar advantag plan might charg beneficiari monthli premium
co-pay medicare-cov servic certain extra benefit
compani medicar hmo ppo plan cover medicare-elig individu resid certain
counti might elimin reduc coinsur level deduct variou medic
servic seek care particip in-network provid emerg situat except
emerg situat specifi plan variou hmo plan provid out-of-network benefit
ppo plan carri out-of network benefit subject higher member cost-shar case
beneficiari requir pay monthli premium hmo ppo plan addit
monthli part premium requir pay medicar program june compani
provid health insur coverag contract approxim million medicar advantag
market profil approxim american health insur coverag
approxim popul coverag privat plan includ manag
healthcar approxim popul coverag provid govern program
includ medicar medicaid around popul million uninsur
last year public healthcar exchang form along medicaid
expans estim coverag type mutual exclus peopl cover
one type health insur year result percentag total
howev accord depart human servic approxim million peopl
enrol insur healthcar exchang think manag care still
good growth prospect among uninsur medicar medicaid popul accord
center medicar medicaid servic million beneficiari -- medicar
popul -- enrol medicar advantag plan decemb
competit landscap accord insur inform institut health
insur compani rank fourth enrol decemb face
substanti competit vari local market includ manag care compani nation
insur compani hmo ppo includ own cross/ shield plan
think tradit involv medicar help give competit advantag
garner addit medicar member medicar advantag program medicar drug program
began januari
financi trend sale increas billion billion repres
three-year compound annual growth rate compound-annual-growth-rate sale aid medicaid expans
individu mandat compon includ within afford act effect start
adjust ep increas repres three-year compound-annual-growth-rate
histor effect tax rate rang howev result tax cut job
act anticip tax rate declin
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
lt debt capit
analysi stock current worth base
cfra proprietari quantit model suggest
slightli overvalu usd
figur base fiscal year-end price
growth rate averag
bullish sinc januari technic indic
bullish
lt debt capit
return equiti
net life insur
balanc sheet data million usd
equival
return revenu
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
fundament outlook manag health
sub-industri next month
posit think largest driver
industri earn growth next year
expand use cheaper gener
drug help contain medic cost health
plan price gain improv economi
margin improv vertic integr
pharmaci benefit manag pbm
provid posit view temper
lower growth total membership expect
come year
banner year first-tim gener
drug first gener approv
fda significantli
new gener come
materi lower cost brand-nam
version compet think
help contain medic cost
sub-industri competit older
gener also intens indic
total fda gener approv
mani compet version gener enter
market gener drug price
experienc sharp declin
expect moder gener
deflat still think lower
gener price contribut medic cost
contain year ahead
anoth factor like help contain
medic cost integr health
insur pbm
acquisit aetna purchas
express script close
also plan launch in-hous pbm
begin think move
provid medic cost ratio
improv suspect pbm captur
materi rebat drug maker
alway pass insur also seen
mani manag care firm activ acquir
healthcar provid unitedhealth
group pend acquisit
medic group think integr also
serv manag care well insur better
control medic cost affili
somewhat moder posit outlook
sub-industri expect slower
growth health plan membership membership
growth often aid employ ad new
hire company-sponsor health plan
view robust job gain may harder
come economi near full
employ repeal individu
mandat may also begin contribut slower
membership growth took effect start
bright side think robust wage
state tax revenu growth off-set slow
individu util rise wage opt
comprehens health insur plan
provid tailwind premium
insur also abl negoti decent
baselin premium increas employ
given health corpor profit
tax reduct medicaid insur
particular well-posit view
total state tax revenu grew averag rate
first three quarter
averag growth
think medicaid insur
negoti better price manag care
contract state budget pressur
low revenu growth
 manag health index
rose vs rise
composit index manag health
index rose vs declin
base index
five-year market price perform feb
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
et cfra keep hold opinion share inc
privat equiti firm tpg capit welsh carson
 stow agre acquir privately-held health servic
one largest hospic oper locat state
second transact privat equiti firm pursu togeth
consortium first deal expect close consortium agre
acquir kindr healthcar separ kindr home health unit kindr
also retain stake kindr
expect combin oper form nation largest hospic oper
howev deal conting upon use cash hand
anticip materi impact earn deal subject
approv expect close remain cautiou
transact concern reimburs pressur yet note
consolid achiev materi cost save /jeffrey loo cfa
et cfra lower opinion share inc hold
buy share significantli pre-market follow
unconfirm report includ wall street journal
preliminari talk acquir howev term potenti deal
still uncertain share trade ep estim
peer near target price fairli valu
report say discuss earli stage think potenti
strateg partnership may make sens potenti deal would
latest among consolid health care space follow
cvs/aetna cigna/express script deal amazon berkshir hathaway
jpmorgan health care partnership pharmaci busi
acquisit would increas leverag lower drug cost provid
access health data enabl steer member
pharmaci compani alreadi partnership place medicar
analyst research note compani news
pm et cfra keep hold opinion share humana inc
drop target ep
estim histor forward price-to-earnings averag due
worse-than-expect margin ep vs
consensu rais ep estim start
oper revenu grew yoy driven primarili higher price
medicar plan membership medicare-focus retail segment
gener approxim oper revenu slightli vs
prior-year period howev think due intens competit among
insur medicar busi yet unlik larg peer
still manag grow medicar membership
substanti medic cost oper expens also grew faster
revenu lead yoy declin adjust pre-tax incom
sg expens ratio bp yoy remain neutral
would like see better execut cost contain /colin scarola
rais target ep estim
premium peer see improv profit medicar
busi ep vs ahead consensu
rais ep estim
strong medicar star rate oper revenu yoy
driven primarili higher price medicar plan medicar
membership roughli flat versu prior-year period also increas
militari servic membership yoy win tricar east region
contract began servic overal benefit cost ratio
improv significantli quarter although
much improv relat reinstat health insur
industri fee rather better perform medic cost contain
remain neutral would like see execut better oper cost
et cfra keep hold opinion share inc
rais target price slightli peer
forward ep estim solid membership growth
ep vs estim howev rais
ep estim continu lower inpati medicar
advantag util expect aid result also rais
ep estim medicar advantag membership rose
individu market group market
encourag abil continu grow within segment
marketplac view one import growth area
also recent award medicaid contract florida serv
addit member increas exist medicaid
membership indic expect complet sale kmg america
long-term care insur subsidiari continent gener insur compani
/jeffrey loo cfa
keep target peer
ep estim account earlier report
talk acquir continu believ
like inclin expand exist partnership
pursu acquisit rais ep estim
ep ahead view sale rose partli
robust increas individu medicar advantag member
group medicar advantag rose potenti regulatori chang
may allow medicar advantag program offer addit servic
like view attract member away choos tradit
medicar retail medic benefit ratio improv aid
reinstat health insur fee expect larger
improv overal medic benefit ratio improv basi point
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
